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Acute Oral Poisoning Due to Chloracetanilide Herbicides
Chloracetanilide herbicides (alachlor, butachlor, metachlor) are used widely. Although 
there are much data about chronic low dose exposure to chloracetanilide in humans and 
animals, there are few data about acute chloracetanilide poisoning in humans. This study 
investigated the clinical feature of patients following acute oral exposure to 
chloracetanilide. We retrospectively reviewed the data on the patients who were admitted 
to two university hospitals from January 2006 to December 2010. Thirty-five patients were 
enrolled. Among them, 28, 5, and 2 cases of acute alachlor, metachlor, butachlor 
poisoning were included. The mean age was 49.8± 15.4 yr. The poison severity score (PSS) 
was 17 (48.6%), 10 (28.6%), 5 (14.3%), 2 (5.7%), and 1 (2.9%) patients with a PSS of 0, 
1, 2, 3, and 4, respectively. The age was higher for the symptomatic patients (1-4 PSS) 
than that for the asymptomatic patients (0 PSS) (43.6 ± 15.2 vs 55.7 ± 13.5). The arterial 
blood HCO3
- was lower in the symptomatic patients (1-4 PSS) than that in the 
asymptomatic patients (0 PSS). Three patients were a comatous. One patient died 24 hr 
after the exposure. In conclusion, although chloracetanilide poisoning is usually of low 
toxicity, elder patients with central nervous system symptoms should be closely monitored 
and cared after oral exposure.
Key Words: Alachlor; Butachlor; Metachlor; Herbicides; Poisoning
Su-Jin Seok
1, Sang–Cheon Choi
2, 
Hyo-Wook Gil
1, Jong-Oh Yang
1, 
Eun-Young Lee
1, Ho-Yeon Song
3, 
and Sae-Yong Hong
1
1Department of Internal Medicine, Soonchunhyang 
University Cheonan Hospital, Cheonan; 
2Department 
of Emergency Medicine, Ajou University School of 
Medicine, Suwon; 
3Department of Microbiology, 
Soonchunhyang University, Cheonan, Korea
Received: 24 August 2011
Accepted: 17 November 2011
Address for Correspondence:
Hyo-Wook Gil, MD
Department of Internal Medicine, Soonchunhyang University 
Cheonan Hospital, 8 Soonchunhyang 2-gil, Cheonan 330-100, 
Korea
Tel: +82.41-570-3671, Fax: +82.41-574-5762
E-mail: hwgil@schmc.ac.kr
*This work was carried out with the support of “Cooperative 
Research Program for Agriculture Science & Technology 
Development (Project No. PJ008246)” Rural Development 
Administration, Republic of Korea. 
http://dx.doi.org/10.3346/jkms.2012.27.2.111  •  J Korean Med Sci 2012; 27: 111-114
ORIGINAL ARTICLE
Occupation & Environmental Medicine
INTRODUCTION 
Chloracetanilide herbicides are widely used in the United States, 
South America and Asian countries. Chloracetanilide herbicides 
are sold as alachlor, butachlor, metachlor and propachlor. This 
class of herbicides can control grasses and broad leaf weeds as 
a systemic herbicide. The herbicide’s mode of action is not total-
ly understood, but it is known that this class of herbicide inhib-
its the biosynthesis of lipids, alcohols, fatty acids, proteins, iso-
prenoids and flavonoids (1, 2). Alachlor is slightly toxic to mam-
mals. The oral LD50 in rats ranges from 930 to 1,350 mg/kg (3). 
Several subchronic and chronic toxicology studies of alachlor 
have been conducted on animals and suggested the possibility 
of carcinogen (4-8). Genotoxicity studies and carcinogenicity 
studies have been conducted for chronic exposure or repeated 
doses of alachlor. Some studies have revealed that chronic ex-
posure to alachlor causes nasal, stomach and thyroid tumors in 
animals. However, human data did not reveal that low exposure 
to alachlor could be carcinogenic (9, 10). 
  Butachlor and metachlor are also widely used in Asia, includ-
ing Korea. These are a subclass of the acetamides, and have sim-
ilar structures with alachlor. There are few data about acute ex-
posure to chloracetanilide in animals or humans. The mecha-
nism of toxicity following acute oral exposure has not been re-
vealed. Lo et al. (11) retrospectively analyzed the cases reported 
to the Taiwan national poison center. Although alachlor and 
butachlor poisonings were usually of low toxicity, three of 113 
patients died after manifesting profound hypotension and/or 
coma following alachlor ingestion. This suggested that alachlor 
poisoning could be fatal. There are few human data about acute 
chloracetanilide poisoning. Such clinical data should be col-
lected and especially the data about the severe cases. 
  Therefore we investigated the clinical features, the poison se-
verity score and the clinical course of patients following acute 
poisonings with three different chloracetanilide herbicides. 
MATERIALS AND METHODS
We retrospectively collected the data from the patients who were 
admitted to Soonchunhyang University Cheonan Hospital Pes-
ticide Poisoning Center and the Ajou University Medical Center 
from January 2006 to December 2010. The subjects included in 
this study were all aged more than 18 yr and they had intentional-
ly taken the poison orally. Patients were excluded if they were 
intoxicated with another pesticide in addition to chloracetanilide.
  Trained physicians treated the patients and recorded all in-
formation on a standardized data-collection form. On admission, 
a standardized questionnaire including demographic charac-Seok S-J, et al.  •  Acute Chloracetanilide Poisoning
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teristics and specific questions about the poisoning (amount of 
drug ingestion, time interval between ingestion and arrival, etc) 
was completed. Clinical toxicology specialist reviewed medical 
records.
  The ingested amount was determined by the reported mouth-
fuls ingested (one mouthful was calculated as 20 mL). The time 
interval between ingestion and arrival at our centers was assessed. 
The following data was collected for each patient: symptoms, 
comorbidity, the poisoning severity score (PSS) within 24 hr fol-
lowing acute chloracetanilide intoxication, the initial laboratory 
parameters and the clinical outcomes (12). The PSS grades the 
severity of poisoning in five levels: 0) No symptoms or signs re-
lated to poisoning; 1) Minor, transient, and spontaneously resolv-
ing symptoms; 2) Pronounced or prolonged symptoms; 3) Se-
vere or life-threatening symptoms; 4) Death. To investigate neph-
rotoxicity, we reviewed the sequential change of serum creati-
nine. We also investigated the incidence of rhabdomyolysis. 
  The symptoms were classified for four categories. The gastro-
intestinal category included nausea, vomiting, diarrhea and ab-
dominal pain. Central nervous system involvement was docu-
mented if the patients presented with a change of mental status 
(alert, drowsy, stupor, coma, seizure). The cardiovascular cate-
gory included hypertension (a systolic blood pressure > 140 
mmHg or a diastolic blood pressure > 90 mmHg), hypotension 
(a systolic blood pressure < 90 mmHg), bradycardia (heart rate 
< 60/min) and tachycardia (heart rate > 100/min). The respira-
tory category included hypoxemia (PaO2 < 60 mmHg in room 
air) and respiratory failure (hypoxemia and require mechanical 
ventilation).
Statistical analysis 
The data were presented as the mean ± standard deviation for 
continuous variables and as frequencies (in percents) for the 
categorical variables the differences between groups were com-
pared with Mann-Whitney U test for continuous variables and 
the chi-square test for categorical variables. A probability P <  
0.05 was considered statistically significant. The statistical anal-
ysis was performed using SPSS for Windows (version 12.0, Chi-
cago, IL, USA).
Ethics statement
This study was approved by Soonchunhyang University Cheon-
an Hospital’s institutional review board (IRB approval number: 
2011-85). Informed consent was waived by the board.
RESULTS
Thirty five patients were included in this study. They ingested 
alachlor (n = 28), metachlor (n = 5) and butachlor (n = 2), re-
spectively. All the patients intentionally ingested the herbicides. 
Table 1. Comparison of the demographic and clinical characteristics between the symptomatic patients and the asymptomatic patients 
Parameters
Total  
(n = 35)
Asymptomatic patients  
(n = 17)
Symptomatic patients  
(n = 18)
P value
Age (yr)     49.8 ± 15.4     43.6 ± 15.2     55.7 ± 13.5 0.013
Gender (Male:Female) 20:15 13:4 7:11 0.025
Hospital duration (day)     5.1 ± 4.7     4.0 ± 1.4     6.2 ± 6.3 0.251
Estimated amount of exposure (mL)     80.0 ± 82.5     52.4 ± 53.1   106.1 ± 97.3 0.077
Time interval between exposure and hospital arrival (hr)     4.2 ± 3.6     4.5 ± 4.7     3.9 ± 2.5 0.825
WBC (/µL)   12,757.1 ± 6,049.4   11,584.7 ± 5,055.6   13,864.4 ± 6,816.2 0.369
Hemoglobin (g/dL)   14.5 ± 1.5   14.7 ± 1.6   14.4 ± 1.5 0.613
Platelet ( × 10
3/µL)   244.1 ± 86.1   221.2 ± 69.2   265.7 ± 96.5 0.072
Albumin (g/dL)      4.4 ± 0.4     4.4 ± 0.4     4.4 ± 0.4 0.883
Total-bilirubin (mg/dL)     0.7 ± 0.3     0.7 ± 0.3     0.7 ± 0.3 0.807
Aspartate aminotransferase (IU/L)     43.6 ± 51.2     32.0 ± 18.0     54.6 ± 68.3 0.232
Alanine aminotransferase (IU/L)     34.3 ± 30.9     31.9 ± 17.9     36.7 ± 40.0 0.568
Blood urea nitrogen (mg/dL)   13.5 ± 5.4   11.8 ± 4.2   15.1 ± 6.0 0.184
Creatinine (mg/dL)     0.8 ± 0.3     0.7 ± 0.2     0.9 ± 0.3 0.369
Sodium (mEq/L) 143.1 ± 4.3 143.0 ± 4.1 143.1 ± 4.5 0.961
Potassium (mEq/L)     3.8 ± 0.5     3.9 ± 0.4     3.7 ± 0.5 0.245
Amylase (IU/L)     182.9 ± 185.3   155.5 ± 82.4     208.7 ± 246.6 0.987
Lipase (IU/L)     55.9 ± 68.7     50.2 ± 41.3     61.2 ± 88.1 0.832
Creatine kinase (IU/L)     180.6 ± 179.0     197.1 ± 230.9     164.1 ± 111.8 0.902
Myoglobin (ng/mL)       79.2 ± 108.0       58.0 ± 104.1       98.8 ± 111.7 0.009
Arterial blood gas analysis
   Ph
   PCO2 (mmHg)
   PO2 (mmHg)
   HCO3
- (mEq/L)
 
    7.4 ± 0.1
  35.6 ± 5.4
    112.4 ± 148.2
   20.1 ± 4.2
 
    7.4 ± 0.1
  36.8 ± 4.0
  87.9 ± 8.8
  21.6 ± 2.0
 
    7.3 ± 0.1
  34.4 ± 6.3
    135.6 ± 206.6
  18.8 ± 5.2
 
0.103
0.173
0.590
0.017
Asymptomatic patients had a 0 poison severity score. Symptomatic patients had a 1-4 poison severity score. Seok S-J, et al.  •  Acute Chloracetanilide Poisoning
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Their mean age was 49.8 ± 15.4 yr. The baseline characteristics 
are shown in Table 1. After ingestion of chloracetanilide herbi-
cide, most of the patients were asymptomatic or mild symptom-
atic (76.2%), but some patients were in a severe condition and 
one patient died. The PSS were as follows: 17 (48.6%) patients 
were PSS 0, 10 (28.6%) patients were PSS 1, 5 (14.3%) patients 
were PSS 2, 2 (5.7%) patients were PSS 3 and 1 (2.9%) patient 
was PSS 4. The age was higher for the symptomatic patients (1-4 
PSS) than for the asymptomatic patients (0 PSS) (Table 1). The 
HCO3
- was lower in the symptomatic patient (1-4 PSS) than that 
in the asymptomatic patients (0 PSS). 
  The serum creatinine was 1.5 mg/dL in 43 yr old man at 3 hr 
after metachlor poisoning. The serum creatinine was normal-
ized (0.9 mg/dL) after hydration. Except this patient, nephrotox-
icity was not observed. 
  The most frequent clinical manifestations were nausea and 
vomiting (Table 2). The central nervous system was normal in 
80% of patients. Three patients were in a coma state at presenta-
tion. The first case was a 65 yr old man. He ingested 300 mL of 
alachlor to commit suicide. When he arrived at our hospital with-
in 4 hr post ingestion, he had generalized tonic seizure and re-
spiratory failure without cardiogenic shock. Benzodiazepine 
(midazolam 0.2 mg/kg bolus, 0.1 mg/kg maintenance) was in-
travenously injected and mechanical ventilation was applied. 
The seizure was not controlled by benzodiazepine, so phenyto-
in (1,000 mg loading, 100 mg q 8 hr maintenance) was adminis-
tered intravenously. Fever then developed followed by rhabdo-
myolysis. After 22 days, mechanical ventilation was weaned. 
  Throughout this series, one fatality occurred. The patient was 
a 75-yr-old woman who ingested 300 mL of alachlor pesticide 
to commit suicide. When she arrived at the emergency room 
after 2 hr following ingestion of alachlor, her blood pressure was 
110/70 mmHg. Soon her blood pressure dropped and her res-
piration was shallow. Inotropic agents were injected and intuba-
tion was done. Mechanical ventilation was applied. Deep coma 
developed within 3 hr after ingestion. She died due to severe 
cardiogenic shock at 24 hr post-ingestion. 
  Among them, the other one patient was a 45-yr-old woman. 
She recovered within 2 days and that patient underwent hemo-
perfusion.
DISCUSSION 
In vivo and vitro studies, chronic exposure to chloracetanilide 
might be involved with neurotoxicity, genotoxicity and carcino-
genicity (4-8). There have been studies on humans to investi-
gate long term occupational exposure to alachlor and the inci-
dence of cancer, the mortality and the effects on ocular health 
(9, 10). The data did not show that chronic exposure to low lev-
els of alachlor was associated with an ocular effect, mortality 
and the incidence of cancer. Therefore it has been known that 
alachlor has low potential for adverse effects among workers 
who are exposed to low levels of alachlor. 
  There might be a difference between chronic exposure and 
acute exposure. The clinical data about chloracetanilide herbi-
cide poisoning is rarely reported, although the herbicide has 
been widely used. So, we thought that some data are needed to 
predict the prognosis of patients with oral exposure and to de-
termine the risk factors for severe symptom, including the effect 
of central nervous system, respiratory and cardiovascular sys-
tems. Lo et al. (11) recently suggested that alachlor and buta-
chlor poisoning is usually of low toxicity. They reported 3 fatali-
ties among 102 patients with oral exposure to alachlor or buta-
chlor. Twenty-five percent of the oral exposure patients showed 
the effects on central nervous system.  
  Our data also showed the effects on central nervous systems 
in 20% of our patients. Among these patients, two patients de-
veloped respiratory failure and one patients died. The cause of 
the central nervous system (CNS) manifestations might be the 
direct effect of alachlor or the solvents added in the herbicides. 
Anyway, CNS effects suggest a severe case, and so clinicians 
should closely observe such a patient and promptly treat a pa-
tient with CNS symptoms after oral exposure to chloracetani-
lide herbicide. 
  We investigated the poison severity score. When comparing 
the asymptomatic patients (0 PSS) with the symptomatic pa-
tients (1-4 PSS), the symptomatic patients were significantly 
older and they had a lower bicarbonate level than the asymp-
tomatic patients. Although there was no statistical significance, 
estimated amount of exposure tended to be larger in the symp-
tomatic patients than in asymptomatic patients. We suggest that 
Table 2. Clinical manifestations of chloracetanilide herbicide poisoning in the 35 pa-
tients
Clinical manifestations No. (%)
Gastrointestinal manifestations
   Nausea
   Vomiting
   Diarrhea
   Abdominal pain 
 
11 (31.4)
16 (45.7)
3 (8.6)
1 (2.9)
Central nervous systems
   Alert
   Drowsiness
   Stupor
   Coma 
 
28 (80.0)
3 (8.6)
1 (2.9)
3 (8.6)
Respiratory manifestations
   Hypoxemia
   Respiratory failure
 
6 (17.1)
2 (5.7)
Cardiovascular manifestations
   Hypotension
   Hypertension
   Bradycardia
   Tachycardia
 
2 (5.7)
2 (5.7)
1 (2.9)
6 (17.1)
Other manifestations
   Rhabdomyolysis
   Fever
   Seizure
 
2 (5.7)
1 (2.9)
1 (2.9)Seok S-J, et al.  •  Acute Chloracetanilide Poisoning
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old age people with an initial low bicarbonate level could de-
veloped symptoms within 24 hr after oral exposure of chlorac-
etanilide herbicide. 
  In our study, two cases of rhabdomyolysis were observed 
among 35 patients. Drug induced myopathy may result from 
several different mechanisms, and these are direct myotoxicity 
(mitochondrial myopathy), immunologically-induced inflam-
matory myopathy and indirect muscle damage (drug-induced 
coma, subsequent ischemic muscle compression, drug-induced 
hypokalemia, drug-induced hyperkinetic states, dystonic states, 
hyperthermia) (13, 14). In our study, one patient had seizure, 
which could have been indirect myotoxicity, but the others had 
no seizure, which suggests direct toxicity. Some studies showed 
that alachlor induced cellular injury were involved with reactive 
oxygen species production (15). So alachlor itself could cause 
muscle injury. There is not much data on herbicide-induced 
myopathy. Further in vivo and vitro studies about pesticide-in-
duced myopathy are needed. 
  Our study has some limitations. First, this study had a retro-
spective design, including the use of data from past medical re-
cords. Second, ours was a small sized study. Although this study 
had some limitations, our data suggested acute oral exposure 
to chloracetanilide could be severe or fatal. 
  In conclusion, although chloracetanilide poisoning is usually 
of low toxicity, elder patients with CNS symptoms should be 
closely monitored and cared after oral exposure.
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